Genmab A/S SEC filings GNMSF
Genmab A/S has 566 filings in SEC EDGAR's recent list, going back to Apr 28, 2008. Its latest annual report, Form 20-F, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| F-6 | Form f-6 | Jul 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 12, 2025 | — |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| 424B4 | Prospectus | Jul 19, 2019 | — |
| F-6EF | Filing | Jul 17, 2019 | — |
| F-1MEF | Filing | Jul 17, 2019 | — |
| S-8 | Employee stock plan registration | Jul 17, 2019 | — |
| FWP | Free writing prospectus | Jul 16, 2019 | — |
| F-1/A | Filing | Jul 16, 2019 | — |
| F-6 POS | Post-effective amendment no. 2 to form f-6 | Jul 15, 2019 | — |
| FWP | Free writing prospectus | Jul 12, 2019 | — |
| FWP | Free writing prospectus | Jul 12, 2019 | — |
| F-1/A | Filing | Jul 9, 2019 | — |
| F-1 | Registration statement (foreign issuer) | May 28, 2019 | — |
| F-6 POS | Filing | Apr 13, 2018 | — |
| F-6 | Filing | May 22, 2013 | — |
| F-6EF | Filing | Jun 2, 2010 | — |
| F-6EF | Form f-6 | Oct 17, 2008 | — |
| F-6EF | Filing | Jun 18, 2008 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GMAB (Nasdaq), GNMSF (OTC)
- Headquarters
- 1253 Copenhagen K, Denmark
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1434265
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.